AngioDynamics (ANGO) CEO James Clemmer Sells Shares

What Happened
James C. Clemmer, President, CEO and a director of AngioDynamics, disposed of a total of 45,711 shares between July 16–20, 2026 to satisfy tax withholding obligations tied to vested restricted stock units (RSUs). The disposals were made at prices ranging from $13.51 to $14.14 and total roughly $630,110. These were exempt dispositions to cover tax liabilities, not open‑market purchases.

Key Details

• Transaction dates and amounts:
  • 2026-07-16: 18,588 shares @ $14.14 = $262,834 (F1)
  • 2026-07-17: 10,649 shares @ $13.51 = $143,868 (F2)
  • 2026-07-19: 11,764 shares @ $13.51 = $158,932 (F3)
  • 2026-07-19: 487 shares @ $13.51 = $6,579 (F4)
  • 2026-07-20: 4,223 shares @ $13.71 = $57,897 (F5)
• Aggregate: 45,711 shares disposed for ~ $630,110.
• Shares owned after transaction: Not provided in the supplied filing excerpt.
• Footnotes: Each disposal was an exempt withholding of shares to satisfy tax obligations from RSU vesting (grants dated 7/16/2025; 7/17/2024; 7/19/2023; 7/19/2024; 7/20/2022).
• Filing: Form 4 filed 2026-07-21 (Period of Report: 2026-07-16); appears timely.
• Transaction code: F = tax withholding / exempt disposition.

Context
These transactions reflect the company withholding vested RSU shares to meet tax obligations (a routine, “cashless” withholding), not necessarily an open‑market sale indicating a change in the insider’s view. For retail investors, outright purchases by insiders tend to be a stronger signal than routine withholding disposals. This Form 4 reports the mechanics of RSU vesting and tax withholding; it does not provide insight into any trading plan or broader strategy.